Photo‐metallo‐immunotherapy: Fabricating Chromium‐Based Nanocomposites to Enhance CAR‐T Cell Infiltration and Cytotoxicity against Solid Tumors
Authors:
Open Access
- 1 July 2024
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 37 (2) , 2407425
Abstract
The infiltration and cytotoxicity of chimeric antigen receptor (CAR)‐T cells are crucial for effective elimination of solid tumors. While metallo‐immunotherapy is a promising strategy that can activate the antitumor immunity, its role in promoting CAR‐T cell therapy remains elusive. The first single‐element nanomaterial based on chromium nanoparticles (Cr NPs) for cancer photo‐metallo‐immunotherapy has been reported previously. Herein, an extended study using biodegradable polydopamine as a versatile carrier for these nanoparticles, enabling synergistic CAR‐T cell therapy, is reported. The results show that these nanocomposites with or without further encapsulation of the anticancer drug alpelisib can promote the CAR‐T cell migration and antitumor effect. Upon irradiation with near‐infrared light, they caused mild hyperthermia that can “warm” the “cold” tumor microenvironment (TME). The administration of B7‐H3 CAR‐T cells to NOD severe combined immunodeficiency gamma mice bearing a human hepatoma or PIK3CA‐mutated breast tumor can significantly inhibit the tumor growth after the induction of tumor hyperthermia by the nanocomposites and promote the secretion of serum cytokines, including IL‐2, IFN‐γ, and TNF‐α. The trivalent Cr3+ ions, which are the major degradation product of these nanocomposites, can increase the CXCL13 and CCL3 chemokine expressions to generate tertiary lymphoid structures (TLSs) in the tumor tissues, facilitating the CAR‐T cell infiltration.Keywords
Funding Information
- National Natural Science Foundation of China (82272779, 82273236, 82202034)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515030182)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20220530141608020, JCYJ20220530141609021)
This publication has 37 references indexed in Scilit:
- The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advancesCell Biochemistry and Function, 2024
- Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathwayClinical and Translational Medicine, 2023
- Highly proliferative and hypodifferentiated CAR-T cells targeting B7–H3 enhance antitumor activity against ovarian and triple-negative breast cancersCancer Letters, 2023
- A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid TumorsAdvanced Materials, 2022
- Engineering Robust Ag‐Decorated Polydopamine Nano‐Photothermal Platforms to Combat Bacterial Infection and Prompt Wound HealingAdvanced Science, 2022
- Magnesium sensing via LFA-1 regulates CD8+ T cell effector functionCell, 2022
- Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapyEuropean Journal of Cancer, 2021
- One‐Pot Synthesis of a Cyclic Antimicrobial Peptide‐Conjugated Phthalocyanine for Synergistic Chemo‐Photodynamic Killing of Multidrug‐Resistant BacteriaAdvanced Therapeutics, 2020
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T CellsAdvanced Materials, 2019
- Understanding the Photothermal Conversion Efficiency of Gold NanocrystalsSmall, 2010